Chin‐Chung Wu

7.6k total citations · 1 hit paper
191 papers, 6.3k citations indexed

About

Chin‐Chung Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Organic Chemistry. According to data from OpenAlex, Chin‐Chung Wu has authored 191 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 36 papers in Cardiology and Cardiovascular Medicine and 34 papers in Organic Chemistry. Recurrent topics in Chin‐Chung Wu's work include Natural product bioactivities and synthesis (23 papers), Traditional and Medicinal Uses of Annonaceae (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). Chin‐Chung Wu is often cited by papers focused on Natural product bioactivities and synthesis (23 papers), Traditional and Medicinal Uses of Annonaceae (19 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). Chin‐Chung Wu collaborates with scholars based in Taiwan, United States and Japan. Chin‐Chung Wu's co-authors include Yang‐Chang Wu, Fang‐Rong Chang, Che‐Ming Teng, Tsong‐Long Hwang, Sheng‐Chu Kuo, Pei‐Wen Hsieh, Fang‐Yu Lee, Kuo Sc, Lee Fy and Feng‐Nien Ko and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Blood.

In The Last Decade

Chin‐Chung Wu

190 papers receiving 6.1k citations

Hit Papers

3‐(9‐Carbazolyl)carbazole... 2007 2026 2013 2019 2007 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chin‐Chung Wu 2.5k 955 678 633 559 191 6.3k
KeWei Wang 2.7k 1.1× 582 0.6× 449 0.7× 548 0.9× 232 0.4× 223 5.7k
Paul K. Witting 3.1k 1.3× 656 0.7× 480 0.7× 1.1k 1.8× 151 0.3× 175 7.4k
Paulo J. Oliveira 5.2k 2.1× 594 0.6× 2.3k 3.4× 1.6k 2.5× 196 0.4× 342 11.6k
Anne Nègre‐Salvayre 4.9k 2.0× 823 0.9× 904 1.3× 2.1k 3.2× 147 0.3× 181 11.8k
Srigiridhar Kotamraju 2.4k 1.0× 686 0.7× 941 1.4× 692 1.1× 209 0.4× 82 5.3k
Takahiro Shibata 4.2k 1.7× 481 0.5× 227 0.3× 620 1.0× 130 0.2× 216 6.7k
Hiroyuki Yasui 1.7k 0.7× 1.4k 1.4× 247 0.4× 609 1.0× 136 0.2× 263 6.7k
Angelika M. Vollmar 4.2k 1.7× 686 0.7× 1.1k 1.6× 857 1.4× 66 0.1× 243 9.8k
Jacek Zielonka 4.0k 1.6× 855 0.9× 310 0.5× 1.7k 2.7× 459 0.8× 143 8.6k
Boyang Yu 5.2k 2.1× 553 0.6× 316 0.5× 514 0.8× 148 0.3× 489 9.5k

Countries citing papers authored by Chin‐Chung Wu

Since Specialization
Citations

This map shows the geographic impact of Chin‐Chung Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Chung Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Chung Wu more than expected).

Fields of papers citing papers by Chin‐Chung Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin‐Chung Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Chung Wu. The network helps show where Chin‐Chung Wu may publish in the future.

Co-authorship network of co-authors of Chin‐Chung Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chin‐Chung Wu. A scholar is included among the top collaborators of Chin‐Chung Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin‐Chung Wu. Chin‐Chung Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chi‐Chuan, et al.. (2025). Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older. BMC Geriatrics. 25(1). 15–15. 1 indexed citations
2.
Tsai, Keng‐Chang, Tingyu Wang, Tzu‐Yin Chen, et al.. (2024). Discovery and biological evaluation of potent 2-trifluoromethyl acrylamide warhead-containing inhibitors of protein disulfide isomerase. European Journal of Medicinal Chemistry. 283. 117169–117169.
3.
Berkecz, Róbert, et al.. (2023). Preparation and Evaluation of 6-Gingerol Derivatives as Novel Antioxidants and Antiplatelet Agents. Antioxidants. 12(3). 744–744. 14 indexed citations
4.
Rédei, Dóra, et al.. (2020). 12-Deoxyphorbol Esters Induce Growth Arrest and Apoptosis in Human Lung Cancer A549 Cells Via Activation of PKC-δ/PKD/ERK Signaling Pathway. International Journal of Molecular Sciences. 21(20). 7579–7579. 16 indexed citations
5.
Cheng, Yuan‐Bin, et al.. (2020). Juglone prevents human platelet aggregation through inhibiting Akt and protein disulfide isomerase. Phytomedicine. 82. 153449–153449. 23 indexed citations
7.
Wu, Yen‐Wen, Wei-Kung Tseng, Hsin-Bang Leu, et al.. (2018). The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease. Scientific Reports. 8(1). 14410–14410. 23 indexed citations
8.
Huang, Chin‐Chou, Hsin-Bang Leu, Wei-Hsian Yin, et al.. (2017). Optimal achieved blood pressure for patients with stable coronary artery disease. Scientific Reports. 7(1). 10137–10137. 11 indexed citations
9.
Tsai, Yu‐Chi, Chia-Chun Hsu, Mohamed El‐Shazly, et al.. (2015). Phytochemicals and Estrogen-Receptor Agonists from the Aerial Parts of Liriope platyphylla. Molecules. 20(4). 6844–6855. 15 indexed citations
10.
Singab, Abdel Nasser B., Mohamed El‐Shazly, Ying-Chi Du, et al.. (2013). Phyto-SERM Constitutes from Flemingia macrophylla. International Journal of Molecular Sciences. 14(8). 15578–15594. 18 indexed citations
11.
Wang, Hui‐Chun, Alan Yueh‐Luen Lee, Wen‐Cheng Chou, et al.. (2012). Inhibition of ATR-Dependent Signaling by Protoapigenone and Its Derivative Sensitizes Cancer Cells to Interstrand Cross-link–Generating Agents In Vitro and In Vivo. Molecular Cancer Therapeutics. 11(7). 1443–1453. 31 indexed citations
12.
Wang, Sheng‐Yang, Chin‐Chung Wu, Wan‐Yu Lin, et al.. (2012). Cytotoxicity, anti-platelet aggregation assay and chemical components analysis of thirty-eight kinds of essential oils. Journal of Food and Drug Analysis. 20(2). 478–483. 9 indexed citations
13.
Wu, Shou-Fang, Tsong‐Long Hwang, Shu‐Li Chen, et al.. (2011). Bioactive components from the heartwood of Pterocarpus santalinus. Bioorganic & Medicinal Chemistry Letters. 21(18). 5630–5632. 25 indexed citations
14.
Hsieh, Pei‐Wen, et al.. (2010). The synthesis and biologic evaluation of anti-platelet and cytotoxic β-nitrostyrenes. Bioorganic & Medicinal Chemistry. 18(21). 7621–7627. 36 indexed citations
15.
Wu, Chin‐Chung. (2009). Imaging reactive oxygen species dynamics in living cells and tissues. Frontiers in Bioscience-Scholar. S1(1). 39–44. 8 indexed citations
16.
Chen, Wen-Ying, et al.. (2008). Tubocapsenolide A, a Novel Withanolide, Inhibits Proliferation and Induces Apoptosis in MDA-MB-231 Cells by Thiol Oxidation of Heat Shock Proteins. Journal of Biological Chemistry. 283(25). 17184–17193. 73 indexed citations
17.
Yang, Shieh‐Yueh, et al.. (2006). Magnetic Nano-Particles and Their Applications in Immunoassays. Journal of the Korean Physical Society. 48(5). 999–1003. 5 indexed citations
18.
Lu, Long‐Sheng, Yen‐Bin Liu, Chia-Wei Sun, et al.. (2006). Optical mapping of myocardial reactive oxygen species production throughout the reperfusion of global ischemia. Journal of Biomedical Optics. 11(2). 21012–21012. 7 indexed citations
19.
Lin, An-Shen, Fang‐Rong Chang, Chin‐Chung Wu, Chih‐Chuang Liaw, & Yang‐Chang Wu. (2005). New Cytotoxic Flavonoids fromThelypteris torresiana. Planta Medica. 71(9). 867–870. 64 indexed citations
20.
Wu, Chin‐Chung, et al.. (2005). 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. European Journal of Pharmacology. 527(1-3). 37–43. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026